Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis. [electronic resource]
Producer: 20080506Description: 523-5 p. digitalISSN:- 1468-3083
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.